ArticleDatabase : the journal of biological databases and curation2014
CBMAR: a comprehensive β-lactamase molecular annotation resource.
Article in Database : the journal of biological databases and curation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Antimicrobial Resistance: Enzymes, Proteins, and Computational Resources.Current pharmaceutical design · 2026Review
- Strategic design of a multi-tier database for class A β-lactamase BlaC variants of M. tuberculosis: advancing the fight against antibacterial resistance.The Journal of antibiotics · 2025Article
- ProtAlign-ARG: antibiotic resistance gene characterization integrating protein language models and alignment-based scoring.Scientific reports · 2025Article
- DRAMMA: a multifaceted machine learning approach for novel antimicrobial resistance gene detection in metagenomic data.Microbiome · 2025Article
- NCRD: A non-redundant comprehensive database for detecting antibiotic resistance genes.iScience · 2023Article
- Comprehensive genomic analysis of hypocholesterolemic probioticFrontiers in nutrition · 2023Article
- Metagenomic-based surveillance systems for antibiotic resistance in non-clinical settings.Frontiers in microbiology · 2022Review
- Text mining for identification of biological entities related to antibiotic resistant organisms.PeerJ · 2022Article
- β-LacFamPred: An online tool for prediction and classification of β-lactamase class, subclass, and family.Frontiers in microbiology · 2022Article
- BacARscan: anBiology methods & protocols · 2022Article
- Investigating the OXA Variants of ESKAPE Pathogens.Antibiotics (Basel, Switzerland) · 2021Article
- DeepBL: a deep learning-based approach for in silico discovery of beta-lactamases.Briefings in bioinformatics · 2021Article
- Forecasting the dissemination of antibiotic resistance genes across bacterial genomes.Nature communications · 2021Article
- BacEffluxPred: A two-tier system to predict and categorize bacterial efflux mediated antibiotic resistance proteins.Scientific reports · 2020Article
- Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species.Scientific reports · 2020Article
- Population Gene Introgression and High Genome Plasticity for the Zoonotic Pathogen Streptococcus agalactiae.Molecular biology and evolution · 2019Article
- Sequencing-based methods and resources to study antimicrobial resistance.Nature reviews. Genetics · 2019Review
- An Integrative Database of β-Lactamase Enzymes: Sequences, Structures, Functions, and Phylogenetic Trees.Antimicrobial agents and chemotherapy · 2019Article
- Using Genomics to Track Global Antimicrobial Resistance.Frontiers in public health · 2019Review
- Multiple Food-Animal-Borne Route in Transmission of Antibiotic-ResistantFrontiers in microbiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
β-Lactam antibiotics are among the most widely used antibiotics against microbial pathogens. However, enzymatic hydrolysis of these antibiotics by bacterial β-lactamases is increasingly compromising their efficiency. Although new generation β-lactam antibiotics have been developed to combat antibiotic resistance, β-lactamases have also evolved along with the new variants of the substrate. A strong selection pressure from the newer generation of β-lactam antibiotics has resulted in evolution of different families within each class of β-lactamase. To facilitate detailed characterization of different families of β-lactamases, we have created a database, CBMAR, which facilitates comprehensive molecular annotation and discovery of novel β-lactamases. As against the limited scope of other existing similar databases, CBMAR provides information useful for molecular and biochemical characterization of each family of β-lactamase. The basic architecture of CBMAR is based on Ambler classification, which divides β-lactamases as serine (Classes A, C and D) and metallo-β-lactamases (Class B). Each class is further divided into several families on the basis of their hydrolytic character. In CBMAR, each family is annotated with (i) sequence variability, (ii) antibiotic resistance profile, (iii) inhibitor susceptibility, (iv) active site, (v) family fingerprints, (vi) mutational profile, (vii) variants, (viii) gene location, (ix) phylogenetic tree and several other features. Each entry also has external links to the relevant protein/nucleotide sequence and structure databases. The database also supports sequence similarity searches using BLAST and assigns a new β-lactamase protein to its respective family on the basis of family-specific fingerprint. Database URL: http://14.139.227.92/mkumar/lactamasedb
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.